Latest News On IBS

• Constella® (Linaclotide), The First Approved Prescription Therapy In A New Class Of Treatments For Adults With IBS-C, Is Now Available In Europe

  Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C[i], in Europe......
  

• New Drugs For IBS, Hepatitis C

  Research presented at Digestive Disease Week® (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C. An international study holds promising results for patients suffering from IBS-D. In the phase II study, researchers found that the drug ibodutant significantly...
  

• The Benefits Of Probiotics For Patients With Stress-Associated Gastrointestinal Disorders

  For those with irritable bowel syndrome who wonder if stress aggravates their intestinal disorder, a new University of Michigan Health System study shows it's not all in their head......
  

• Studying The Causes Of Irritable Bowel Syndrome - GENIEUR

  Experts and scientists from 19 European countries are getting together to investigate the causes of IBS (irritable bowel syndrome) with the aim of better understanding the condition and improving diagnosis and treatment. The team is led by researchers from the Sahlgrenska Academy, University of...
  

• Linzess (Linaclotide) For IBS With Constipation Or Chronic Idiopathic Constipation Now Available, USA

  Linzess (linaclotide), a medication for irritable bowel syndrome (IBS) with constipation or chronic idiopathic constipation is now available in American pharmacies, Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc announced......